This website is provided for informational purposes only and does not constitute an offer to purchase or subscribe to shares, portfolios, or shares of any Cell, nor does it serve as an advertisement in any jurisdiction where such shares, portfolios, or Cells are not registered or authorised for sale. Cogent Asset Management Ltd holds Fund Management License number FML/18/0040A, granted under the Labuan Financial Services and Securities Act 2010. The registered address of Cogent Asset Management Ltd is: Unit Level 9(F)2, Main Office Tower, Financial Park Complex, Jalan Merdeka, Labuan F.T 87000, Malaysia. The information provided is believed to be accurate as at the date of publication and has been obtained from sources considered reliable. However, no warranty or representation is given as to its accuracy or completeness. The information may be subject to change at any time without notice. Past performance is not indicative of future results. The value of shares, portfolios, or Cells and the income they generate may fall as well as rise. Investments may be affected by currency fluctuations, which can either increase or reduce their value. Due to ongoing market volatility and exchange rate fluctuations, investment performance may vary significantly over short periods. Investors should be aware that all financial instruments carry inherent risks, including the potential loss of invested capital. Unless otherwise stated, performance is calculated based on the Net Asset Value (NAV) and assumes the reinvestment of dividends. Performance figures do not take into account fees or charges related to subscriptions or redemptions. The full documentation required to make an investment—including the Scheme Particulars, Offering Memorandum, and relevant Supplements—is available upon request from Cogent Asset Management Ltd. Before making any investment decision, investors are strongly advised to consult with their financial adviser, legal adviser, or tax adviser, and carefully review all relevant documents, including the most recent annual report and the Offering Memorandum. These documents contain specific risk disclosures, applicable restrictions, and the basis for dealing. Where investors choose not to seek independent advice, they should carefully consider whether the investment in shares, portfolios, or Cells is appropriate in light of their personal circumstances and investment objectives.
